ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Patient Outcomes, Preferences, and Attitudes Poster II

Date: Sunday, November 13, 2022

Time: 1:00PM-3:00PM

Meeting: ACR Convergence 2022

1:00PM-3:00PM
Abstract Number: 1346
“Finally, I Can Do Something About It Myself”: A Process Evaluation of the Plants for Joints Lifestyle Intervention
1:00PM-3:00PM
Abstract Number: 1350
A Prospective Study on Pain Associated with Injection of Needles: PAIN Study
1:00PM-3:00PM
Abstract Number: 1358
Adherence to Early DMARD Strategies in Newly Diagnosed RA Patients Seen in Routine Care: Results from the Canadian Early Arthritis Cohort Study
1:00PM-3:00PM
Abstract Number: 1335
Artificial Intelligence–enabled Sentiment Analysis of Public Attitude Toward Pregnancy in Lupus Social Media Group
1:00PM-3:00PM
Abstract Number: 1341
Clinical Outcomes of COVID-19 Vaccination and Booster in Patients with Autoimmune Inflammatory Rheumatic Diseases
1:00PM-3:00PM
Abstract Number: 1351
Development, Implementation, and Usability Testing of a New Rheumatoid Arthritis Patient-Reported Outcomes EHR-based Dashboard: A Mixed-Method Study
1:00PM-3:00PM
Abstract Number: 1337
Dietary Mineral Intake of an Inner-City Population and Its Impact on Disease Activity in Patients with SLE
1:00PM-3:00PM
Abstract Number: 1353
Dietary Practices and Beliefs of Patients with Rheumatic Diseases and Relationship with Symptoms: Results of a Multicenter Cross-sectional Study
1:00PM-3:00PM
Abstract Number: 1354
Early Real-World Effectiveness of Upadacitinib in Rheumatoid Arthritis Using Patient-Reported Outcomes Collected via Mobile Application
1:00PM-3:00PM
Abstract Number: 1334
Exploring Canadian Patient Experiences of Living with Lupus Nephritis (LN)
1:00PM-3:00PM
Abstract Number: 1339
Impact of the COVID-19 Pandemic on Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)
1:00PM-3:00PM
Abstract Number: 1352
Improving Completion Rates of Routine Mental Health Screening for Depression and Anxiety in Paediatric Lupus Outpatient Clinic to Enhance Patient Mental Health Care
1:00PM-3:00PM
Abstract Number: 1345
Is Perceived Stress Associated with COVID-19 or Having a Systemic Rheumatic Disease?
1:00PM-3:00PM
Abstract Number: 1340
Nutrition-Related Behaviors and Beliefs – A Survey of Rheumatic Disease Patients
1:00PM-3:00PM
Abstract Number: 1333
Patient Perceptions of Rheumatoid Arthritis Blood Work: A Cross-sectional Survey in the ArthritisPower Registry
1:00PM-3:00PM
Abstract Number: 1356
Patient-perceived Disease Burden and Self-reported Medication Adherence in Systemic Autoimmune Diseases: A Monocentric Observational Study
1:00PM-3:00PM
Abstract Number: 1344
Patient-reported Outcomes in Lupus Low Disease Activity State: Impact of Fatigue
1:00PM-3:00PM
Abstract Number: 1338
Patients’ Perspectives and Experiences of Medication Use in Osteoporosis – a Qualitative Systematic Review and Thematic Synthesis
1:00PM-3:00PM
Abstract Number: 1347
Poor Health-Related Quality of Life in Patients with Lupus Nephritis
1:00PM-3:00PM
Abstract Number: 1349
Priority Educational Topics to Deliver Information About Immune Checkpoint Inhibitors for Patients with Cancer and a Pre-Existing Autoimmune Disease
1:00PM-3:00PM
Abstract Number: 1336
Productivity Analysis in Patients with Idiopathic Inflammatory Myopathies and Relationship with Quality of Life and Emotional Domain: Preliminary Data from a Monocentric Cohort
1:00PM-3:00PM
Abstract Number: 1342
Quality Improvement: Communicating Risk Regarding JAK Inhibitor Use in Rheumatology Patients
1:00PM-3:00PM
Abstract Number: 1355
Relationships Between Work Productivity, Activity Impairment, and Select Patient-Reported Outcomes in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of Two Placebo-Controlled Trials
1:00PM-3:00PM
Abstract Number: 1343
Satisfaction with Rheumatoid Arthritis Care Is Related to Discordance with Providers’ Treatment Goals and Patients’ Reasons for Disagreement
1:00PM-3:00PM
Abstract Number: 1357
The ANCA-Associated Vasculitis Patient-Reported Outcome (AAV-PRO) Captures Depression and Health-Related Quality of Life More Than Disease Activity and Damage
1:00PM-3:00PM
Abstract Number: 1359
Usability and Acceptability of a Digital Behavioral Therapy for the Management of Fibromyalgia
1:00PM-3:00PM
Abstract Number: 1348
We Asked Patients and Families: What Is the Job of a Pediatric Rheumatologist?
1:00PM-3:00PM
Abstract Number: 1332
What Education Topics and Smartphone App Functions Do Rheumatology Patients Consider Important? Survey of Patients in a Community-Based Practice Network

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology